Cannabis Rescheduling: Page 9

US Congressman Attempts to Sway DEA From Rescheduling Cannabis

Rep. Andy Harris claims the FDA’s eight-factor analysis on cannabis was “flawed,” leading to a “misguided” recommendation to reschedule.

12 US Senators Say Cannabis Should Be Descheduled, Demand Transparency From DEA

The dozen Democrats requested responses to six questions regarding the DEA’s rescheduling process.

Biden Reaffirms Cannabis Stance During Campaign Stop

The president said he’s kept his promise on reform during a political event at South Carolina’s First-in-the-Nation dinner.

Gillibrand, Nadler Joined by New York Leaders in Calling DEA to Deschedule Cannabis

Seven New York Democrats from all elected levels united with NORML, business leaders and advocates in Harlem to push for full removal.

Rescheduling, Legalization Prospects Top CBT's Most-Read Articles in January

Here are Cannabis Business Times’ top 10 stories this month.

7 Takeaways From the Feds' Cannabis Rescheduling Recommendation

Attorney Jonathan Havens outlines what stood out for him most after reviewing the 252-page document released by the U.S. Department of Health & Human Services.

The Unredacted HHS Docs Spell Out the Feds' Stance on Cannabis. So, What Comes Next?

Attorney Shane Pennington asks the pertinent questions: What do these documents say? What do they mean? What difference do they make?

Colorado Attorney General Leads Multistate Effort to Support Cannabis Rescheduling

Attorney General Phil Weiser spearheaded a letter signed by 11 other state attorneys general to encourage the Drug Enforcement Administration to reclassify cannabis as a Schedule III drug under the Controlled Substances Act.

Cannabis Rescheduling Document Details Rationale For Schedule III Recommendation

After multiple FOIA requests and a lawsuit, the U.S. Department of Health & Human Services released more than 250 pages explaining the reasoning for recommending that cannabis be reclassified as a Schedule III drug.

DOJ Official Says HHS Will Release Unredacted Cannabis Rescheduling Recommendation Letter

Attorney Matthew Zorn announced that, in response to his FOIA lawsuit, an official confirmed the Department of Health & Human Services would release “the letter and its enclosures in their entirety.”

US Congressman Urges DEA to Expedite Rescheduling Cannabis

Rep. Steve Cohen of Tennessee wrote a letter to Administrator Anne Milgram pushing to initiate the rulemaking process “quickly.”

Industry Attorney Weighs in on Possible Cannabis Rescheduling Timeline: ‘It Normally Takes Years and Years for This to Get Done’

Despite the U.S. Drug Enforcement Administration’s recent response to a letter from Rep. Earl Blumenauer urging the agency to deschedule cannabis, Porter Wright Morris & Arthur’s Shane Pennington says it could be after the 2024 election before federal officials come to a decision on cannabis’s Schedule I status.

Previous Page

Page 9 of 12

Next Page